A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
12/2001
12/19/2001	EP1163524A2 Methods of screening for colorectal cancer modulators
12/19/2001	EP1163373A1 Antisense modulation of cellular inhibitor of apoptosis-1 expression
12/19/2001	EP1163356A1 Retroviral vectors comprising functional and non-functional splice donor and splice acceptor sites
12/19/2001	EP1163355A1 Anti-neoplastic viral agents comprising toxin gene under control of tumour cell-derived transcription factors
12/19/2001	EP1163345A1 Fungal beta-tubulin genes
12/19/2001	EP1163336A2 Vertebrate protein slit, dna sequence encoding it and uses thereof
12/19/2001	EP1163335A1 MATERIALS AND METHODS RELATING TO MODULATION OF p66 EXPRESSION
12/19/2001	EP1163334A1 Polynucleotide and deduced amino acid sequences from stromal cells
12/19/2001	EP1163331A1 50 human secreted proteins
12/19/2001	EP1163272A1 Antibodies specific for cyp1b1
12/19/2001	EP1163267A1 47 human secreted proteins
12/19/2001	EP1163264A1 Novel lhrh antagonists with improved solubility characteristics
12/19/2001	EP1163262A1 Phenylalanine derivatives
12/19/2001	EP1163256A1 Immunomodulatory steroids, in particular the hemihydrate of 16.alpha.-bromoepiandrosterone
12/19/2001	EP1163255A1 50 human secreted proteins
12/19/2001	EP1163254A2 Trpm-2 antisense therapy
12/19/2001	EP1163252A2 Compositions, kits, and methods relating to the human fez1 gene, a novel tumor suppressor gene
12/19/2001	EP1163247A1 Pharmaceutical compositions comprising metal complexes
12/19/2001	EP1163246A1 Organic-arsenic compounds
12/19/2001	EP1163244A1 Thienopyrimidine compounds, their production and use
12/19/2001	EP1163243A2 Calanolides for inhibiting btk
12/19/2001	EP1163242A2 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
12/19/2001	EP1163238A1 Chemokine recpetor binding heterocyclic compounds
12/19/2001	EP1163228A1 Quinazolines and therapeutic use thereof
12/19/2001	EP1163227A1 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, and processes for preparing them
12/19/2001	EP1163225A1 Compounds and methods for modulation of estrogen receptors
12/19/2001	EP1163219A1 Substituted 1-oxo- and 1,3-dioxoisoindolines and their use in pharmaceutical compositions for reducing inflammatory cytokine levels
12/19/2001	EP1163215A1 Amino-thio-acrylonitriles as mek inhibitors
12/19/2001	EP1163213A1 Hydroxamic and carboxylic acid derivatives
12/19/2001	EP1163208A2 Caspase inhibitors and uses thereof
12/19/2001	EP1163195A1 Thiourea and urea liquid-phase combinatorial libraries: synthesis and apoptosis induction
12/19/2001	EP1163011A2 Fatty acid-anticancer conjugates and uses thereof
12/19/2001	EP1162993A2 Use of casb616 polypeptides and polynucleotides for cancer treatment
12/19/2001	EP1162985A1 Matrix protein compositions for induction of apoptosis
12/19/2001	EP1162984A2 Use of cross linked polysaccharides for the inhibition of angiogenesis
12/19/2001	EP1162982A2 Use of stabilised oligonucleotides for preparing a medicine with antitumour activity
12/19/2001	EP1162981A1 Treatment of accidental extravasation of anthracyclines
12/19/2001	EP1162979A2 Cyclic glycerophosphates and analogs thereof
12/19/2001	EP1162978A1 Method for treating and/or preventing retinal diseases with sustained release corticosteroids
12/19/2001	EP1162974A1 Quinazoline formulations and therapeutic use thereof
12/19/2001	EP1162968A1 Use of epigallocatechin-gallate for inhibiting angiogenesis
12/19/2001	EP1162961A2 REGULATION OF HER2/neu ONCONGENE EXPRESSION BY SYNTHETIC POLYAMIDES
12/19/2001	EP1162959A2 Pharmaceutical compositions comprising cyclic glycerophosphates and analogs thereof for promoting neural cell differentiation
12/19/2001	EP1162953A2 Mechanically stable pharmaceutical presentation form containing liquid or semi-solid surface-active substances
12/19/2001	EP1162884A1 Oral low dose butyrate compositions
12/19/2001	EP1094816A4 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
12/19/2001	EP0983063B1 Pharmaceutical composition containing uscharin
12/19/2001	EP0980349B1 Process for producing conjugated linolenic acid-based synthetic triglycerides
12/19/2001	EP0979093B1 Arrestable therapeutic viral agent
12/19/2001	EP0971717B1 Cytotoxic amino sugar and related sugar derivatives of indolopyrrolocarbazoles
12/19/2001	EP0957920B1 Reducing toxic effects of carboplatin using dithioethers
12/19/2001	EP0935605A4 Nucleic acid molecule encoding a bifunctional protein, the protein so encoded and uses thereof
12/19/2001	EP0912573B1 Camptothecin-skeleton compounds isolated from mappia foetida and the use thereof as syntones for novel medicaments as well as therapeutical agents
12/19/2001	EP0854681B1 Therapeutic diet for dogs with lymphoma
12/19/2001	EP0813520B1 Arylsulfonylamino hydroxamic acid derivatives
12/19/2001	EP0781281B1 Beta-carboline derivatives as melatonin agonists, methods for their preparation and their use as drugs
12/19/2001	EP0758387B1 Thymidine kinase mutants
12/19/2001	EP0707849B1 Use of derivatives of 2,4-disubstituted phenols as 5-lipoxigenase inhibitors
12/19/2001	EP0683665B1 Magnetically responsive composition for carrying biologically active substances and methods of production and use
12/19/2001	EP0623215B1 Methods and compositions for diagnosing cat scratch disease and bacillary angiomatosis
12/19/2001	EP0528820B2 Methods and compositions for the identification, characterization and inhibition of farnesyl protein transferase
12/19/2001	EP0437488B2 Animal model for human disease
12/19/2001	CN1327450A Regulatory/unfolding peptides of ezrin
12/19/2001	CN1327449A Human cervical cancer 1 protooncogene and protein encoded therein
12/19/2001	CN1327388A Modified antibodies of induced anti-idiotype reaction enhancement
12/19/2001	CN1327065A New polypeptide-human biphenyl hydrolase-relative protein (Bph-rp) 16.06 and polynucleotide for encoding such polypeptide
12/19/2001	CN1326992A Gene cloning, product preparation and use of Chinese interleukin-18 subtype (53 Arg IL-18)
12/19/2001	CN1326982A New polypeptide-pogo transposon 18 and polynucleotide for encoding such polypeptide
12/19/2001	CN1326947A Human thymosin alpha protogene mutant synthesis, expression and use
12/19/2001	CN1326945A New polypeptide-zinc finger protein 79.46 and polynucleotide for encoding such polypeptide
12/19/2001	CN1326928A Biphenyl sulfonyl amino-cyanogen, its preparing method and use as medicine thereof
12/19/2001	CN1326786A Anti-cancer medicine composition
12/19/2001	CN1326785A Anti-cancer medicine composition
12/19/2001	CN1326772A Medicine for curing carcinoma of esophagus and its preparing method
12/19/2001	CN1326762A Chinese patent medicine for preventing and curing cancer
12/19/2001	CN1076347C 25-hydroxy-16-one-26.28-bishomo-cholecalciferols
12/19/2001	CN1076197C Medicine for curing mastosis
12/18/2001	US6331642 Vitamin D3 analogs
12/18/2001	US6331635 Taxoids, their preparation and pharmaceutical compositions containing them
12/18/2001	US6331621 Nucleotide sequences coding protein with enzymatic activity; for use in treatment of glomeronephritis, fibrosis, cirrhosis, cancer and arthritis
12/18/2001	US6331615 Nucleic acid molecule encoding heavy or light chain of an antibody which specifically recognizes a protein specifically recognized by monoclonal antibody 5c8 (anti-CD40 ligand)
12/18/2001	US6331570 Active enantiomer of RARγ-specific agonist
12/18/2001	US6331564 Use of triaryl methane compounds for inhibiting unwanted cellular proliferation associated with inflammatory disease
12/18/2001	US6331562 Compounds and methods for modulation of estrogen receptors
12/18/2001	US6331559 Lipoic acid derivatives and their use in treatment of disease
12/18/2001	US6331552 Therapy and prophylaxis of inflammatory disorders, for example of rheumatoid arthritis, or of allergic disorders
12/18/2001	US6331546 Use of 2-amino-3,4-dihydroquinazolines for the production of a medicament for the treatment or prophylaxis of illnesses caused by ischemic conditions
12/18/2001	US6331539 Sulfonamide and sulfamide substituted imidazoquinolines
12/18/2001	US6331526 Method of inhibiting the proliferation and causing the differentiation of cells with IGF-1 receptor antisense oligonucleotides
12/18/2001	US6331433 Human T cell leukemia cell line designated D1.1
12/18/2001	US6331425 Nucleotide sequences coding enzymatic polypeptide; for use in the diagnosis and treatment of cancer, meningitis and urogenital disorders; for sequencing preferential oligosaccharides
12/18/2001	US6331423 Nucleotide sequences coding polypeptide for use as human therapeutic agents that modulate kinase activity
12/18/2001	US6331409 Methods and compositions for wound healing
12/18/2001	US6331301 Isolated dna sequences which encodes amino acid sequence in protein;
12/18/2001	US6331286 Methods for high energy phototherapeutics
12/18/2001	US6331175 Method and kit for imaging and treating organs and tissues
12/18/2001	CA2221448C Antisense oligonucleotide modulation of raf gene expression
12/18/2001	CA2178161C Indole derivatives
12/18/2001	CA2085589C Benzoquinazoline compounds
12/13/2001	WO2001094621A1 Screening method for modulators of suv39h2-methyltransferase

1 ... 1762 1763 1764 1765 1766 1767 1768 1769 1770 1771 1772 1773 1774 1775 1776 1777 1778 1779 1780 1781 1782 ... 2211